Romano Brothers & Co’s Chemours CC Stock Holding History

Romano Brothers & Co’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-3,520	Closed	-$108K	–	402
2022 Q4	$108K	Buy	+3,520	New	+$106K	0.02%	363

Other funds holding CC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Romano Brothers & Co's CC Position: Q1 2023 in Review

Romano Brothers & Co sold out of Chemours (CC) in Q1 2023, closing a stake of 3,520 shares — an estimated $108K sold.

Romano Brothers & Co first reported a position in CC in Q4 2022 and held it in 1 quarter. The position peaked at $108K in Q4 2022. 487 funds tracked by Wall St. Rank hold CC as of Q1 2023.

Romano Brothers & Co reported no remaining Chemours position as of Q1 2023 after selling out during the quarter.
Romano Brothers & Co sold 3,520 Chemours shares in Q1 2023, an estimated $108K.
Romano Brothers & Co first reported a position in Chemours in Q4 2022 and held it in 1 quarter.
Romano Brothers & Co's Chemours position peaked at $108K in Q4 2022.
487 funds tracked by Wall St. Rank held Chemours as of Q1 2023.

Based on Romano Brothers & Co's 13F filing for Q1 2023, filed 13 Apr 2023.